Cetera Advisors’s Johnson & Johnson JNJ Stock Holding History

Cetera Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$43.4M	Buy	274,630 +114,547	+72%	+$18.2M	0.34%	53
2023 Q4	$25.1M	Buy	160,083 +12,940	+9%	+$1.98M	0.35%	64
2023 Q3	$22.9M	Sell	147,143 -2,482	-2%	-$410K	0.36%	57
2023 Q2	$24.8M	Buy	149,625 +3,682	+3%	+$594K	0.39%	47
2023 Q1	$22.6M	Sell	145,943 -613	-0.4%	-$99K	0.38%	50
2022 Q4	$25.9M	Buy	146,556 +11,762	+9%	+$2.03M	0.47%	42
2022 Q3	$22M	Buy	134,794 +1,099	+0.8%	+$186K	0.58%	34
2022 Q2	$23.7M	Sell	133,695 -4,783	-3%	-$852K	0.54%	34
2022 Q1	$24.5M	Buy	138,478 +10,552	+8%	+$1.8M	0.49%	38
2021 Q4	$21.9M	Sell	127,926 -12,074	-9%	-$1.98M	0.44%	37
2021 Q3	$22.6M	Buy	140,000 +20,298	+17%	+$3.46M	0.44%	35
2021 Q2	$19.7M	Buy	119,702 +2,184	+2%	+$362K	0.47%	35
2021 Q1	$19.3M	Buy	117,518 +19,723	+20%	+$3.19M	0.53%	31
2020 Q4	$15.4M	Buy	97,795 +13,337	+16%	+$1.97M	0.49%	37
2020 Q3	$12.6M	Buy	84,458 +11,346	+16%	+$1.68M	0.47%	37
2020 Q2	$10.3M	Buy	73,112 +5,117	+8%	+$746K	0.44%	41
2020 Q1	$8.92M	Sell	67,995 -203	-0.3%	-$28.8K	0.48%	37
2019 Q4	$9.95M	Sell	68,198 -7,208	-10%	-$978K	0.42%	41
2019 Q3	$9.76M	Sell	75,406 -3,269	-4%	-$431K	0.43%	42
2019 Q2	$11M	Buy	78,675 +3,204	+4%	+$444K	0.49%	38
2019 Q1	$10.6M	Buy	75,471 +3,307	+5%	+$443K	0.53%	34
2018 Q4	$9.32M	Buy	72,164 +8,710	+14%	+$1.21M	0.54%	35
2018 Q3	$8.79M	Buy	63,454 +3,001	+5%	+$399K	0.43%	42
2018 Q2	$7.32M	Sell	60,453 -213	-0.4%	-$26.6K	0.42%	42
2018 Q1	$7.79M	Sell	60,666 -1,944	-3%	-$263K	0.47%	39
2017 Q4	$8.75M	Sell	62,610 -589	-0.9%	-$82K	0.53%	31
2017 Q3	$8.23M	Sell	63,199 -1,682	-3%	-$223K	0.5%	34
2017 Q2	$8.58M	Buy	64,881 +1,204	+2%	+$154K	0.54%	30
2017 Q1	$7.91M	Buy	63,677 +1,989	+3%	+$238K	0.53%	34
2016 Q4	$7.11M	Sell	61,688 -49	-0.1%	-$5.66K	0.54%	35
2016 Q3	$7.3M	Buy	61,737 +3,507	+6%	+$425K	0.56%	33
2016 Q2	$7.04M	Sell	58,230 -19,102	-25%	-$2.17M	0.55%	35
2016 Q1	$8.36M	Buy	77,332 +23,703	+44%	+$2.45M	0.7%	29
2015 Q4	$5.5M	Buy	53,629 +5,021	+10%	+$505K	0.47%	39
2015 Q3	$4.53M	Sell	48,608 -6,221	-11%	-$602K	0.43%	47
2015 Q2	$5.34M	Buy	54,829 +2,964	+6%	+$297K	0.46%	46
2015 Q1	$5.22M	Buy	51,865 +3,049	+6%	+$310K	0.48%	39
2014 Q4	$5.1M	Buy	48,816 +3,928	+9%	+$414K	0.5%	37
2014 Q3	$4.79M	Buy	44,888 +679	+2%	+$70.4K	0.36%	38
2014 Q2	$4.62M	Buy	44,209 +5,040	+13%	+$509K	0.52%	35
2014 Q1	$3.85M	Sell	39,169 -1,788	-4%	-$166K	0.53%	36
2013 Q4	$3.75M	Buy	40,957 +5,518	+16%	+$509K	0.55%	38
2013 Q3	$3.07M	Buy	35,439 +1,717	+5%	+$154K	0.55%	42
2013 Q2	$2.89M	Buy	+33,722	New	+$2.86M	0.6%	37

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cetera Advisors's JNJ Position: Q1 2024 in Review

Cetera Advisors increased its Johnson & Johnson (JNJ) stake by 72% in Q1 2024, buying an estimated $18.2M and bringing the position to 274,630 shares worth $43.4M. The position accounts for 0.34% of the portfolio, ranked #53.

Cetera Advisors first reported a position in JNJ in Q2 2013 and has held it in 44 quarters since. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

Cetera Advisors held 274,630 shares of Johnson & Johnson worth $43.4M as of Q1 2024.
Cetera Advisors bought 114,547 Johnson & Johnson shares in Q1 2024, an estimated $18.2M.
Johnson & Johnson made up 0.34% of Cetera Advisors's portfolio in Q1 2024, its #53 holding.
Cetera Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 44 quarters since.
3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.